ACADIA PHARMACEUTICALS INC. (ACAD) Capital expenditures 2016–2025
ACADIA PHARMACEUTICALS INC. (ACAD) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$4.7MFY2025 · since FY2016: $1.5M → $4.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $4.7M | +796.7% |
| FY2024 | $523,000 | +946.0% |
| FY2023 | $50,000 | — |
| FY2022 | $0 | -100.0% |
| FY2021 | $1.1M | -85.2% |
| FY2020 | $7.6M | +572.0% |
| FY2019 | $1.1M | -46.3% |
| FY2018 | $2.1M | +159.1% |
| FY2017 | $812,000 | -46.1% |
| FY2016 | $1.5M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice